Factor VIII inhibitors.

doi:10.1097/00062752-199502050-00007

Back to search

Article

Factor VIII inhibitors.

Current opinion in hematology - 1 Sept 1995

Hoyer L W

Abstract excerpt

The development of a Factor VIII inhibitor, an antibody that blocks its procoagulant function, is one of the most serious complications of hemophilia A treatment. Similar antibodies are also recognized as a rare cause of bleeding in previously healthy individuals who develop autoimmune anti-Facto...

Topics

Antibody Formation
Autoantibodies
Factor VIII
Genetic Predisposition to Disease
Hemophilia A
Humans

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.